- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04285203
Living Donation and Kidney Transplantation Information (KIDNEYTIME)
February 25, 2020 updated by: Liise Kayler, State University of New York at Buffalo
Living Donation and Kidney Transplantation Information Made Easy (KIDNEYTIME) With Animated Video Education
The purpose of this study is to increase awareness and knowledge regarding the risks and benefits of kidney transplantation and living donation amongst patients seeking kidney transplantation and their family and friends in Buffalo, New York.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This prospective randomized parallel controlled trial of kidney transplant candidates receiving and educational intervention and standard of care education versus standard of care education only to improve informed decision making about kidney offers.
Study Type
Interventional
Enrollment (Actual)
144
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14215
- Erie County Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- be 18 years or older,
- understand and read English (or have a support person that helps them)
- have acceptable vision to watch videos
- be able to give consent
Exclusion Criteria:
- incarcerated
- involved in the former modeling phase of animation development.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Educational Video
Participants were exposed to 2 educational videos in addition to standard of care education.
|
Educational videos
|
|
No Intervention: Standard of Care
Participants received standard of care education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in knowledge
Time Frame: Baseline and immediately post exposure
|
Assessed by knowledge survey pre and post exposure.
|
Baseline and immediately post exposure
|
|
Change in attitude about kidney offers
Time Frame: Baseline and immediately post exposure
|
Assessed by attitude survey pre and post exposure.
|
Baseline and immediately post exposure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in subjective decisional self-efficacy
Time Frame: Baseline and immediately post exposure
|
Assessed by self-efficacy survey pre and post exposure.
|
Baseline and immediately post exposure
|
|
Participation and decision making
Time Frame: 1 day (During standard of care education at time of clinic visit)
|
Number of questions and value statements in regards to organ offers.
|
1 day (During standard of care education at time of clinic visit)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Liise Kayler, MD, University at Buffalo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 8, 2019
Primary Completion (Actual)
August 29, 2019
Study Completion (Actual)
February 10, 2020
Study Registration Dates
First Submitted
February 10, 2020
First Submitted That Met QC Criteria
February 25, 2020
First Posted (Actual)
February 26, 2020
Study Record Updates
Last Update Posted (Actual)
February 26, 2020
Last Update Submitted That Met QC Criteria
February 25, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00002771
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Transplantation
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedKidney Transplantation | Renal Transplantation | Transplantation, Kidney | Grafting, Kidney | Transplantation, RenalBelgium, Germany, Spain, Sweden, Italy, Switzerland, United Kingdom, Austria, France, Poland, Czech Republic, Netherlands
-
Bristol-Myers SquibbCompletedKidney Transplantation: Transplantation, Kidney
-
Hospices Civils de LyonCompletedKidney Transplantation | Pancreas-kidney TransplantationFrance
-
Nantes University HospitalTerminated
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
The Hospital for Sick ChildrenCompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCanada
-
Medical University of ViennaUnknownKidney Function After Transplantation | Outcome After Kidney Transplantation
Clinical Trials on Educational Video Intervention
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedSkin Carcinoma | Skin MelanomaUnited States
-
University of PadovaAzienda Ulss 6 EuganeaNot yet recruiting
-
Siriraj HospitalCompleted
-
Johns Hopkins UniversityCompletedUrinary Incontinence | Pelvic Organ Prolapse | Patient EducationUnited States
-
The Alternative Sexualities Health Research AllianceTerminatedPre-Exposure ProphylaxisUnited States
-
Wolfson Medical CenterNot yet recruitingAnxiety | Trial of Labor After Cesarean | TOLAC | Previous Cesarean Delivery
-
University of ChicagoNorthwestern University; National Opinion Research CenterCompletedCommunication | Behavior | LanguageUnited States
-
St. Joseph's Healthcare HamiltonNot yet recruitingBody Image | Eating, Healthy
-
Drexel UniversityCompletedOther Surgical Procedures
-
American Heart AssociationEnrolling by invitation